Continuous Disclosure: Who's next on private equity shopping list?
Market news and opinion updated throughout the week.
AdvertisementAdvertise with NZME.
Latest fromMarkets
Who could be next on private equity's shopping list?
Who could be next on the buy list for private equity?
Michael Hill registers slight lift in Xmas sales
Michael Hill registered sales increases over November and December.
Security breach at cryptocurrency company investigated
A significant value of crypto-currency may be involved.
Gas halt likely to lift power prices
Production from the offshore Pohokura gas field is to be cut for a third time next month.
The stock market has been going down, down, down. So why do so many analysts think it'll go way up this year?
Despite carnage last year, analysts still think there's reason to be bullish this year.
NZ dollar heading for 5.4 percent decline in 2018
US interest rates have weighed on the NZ dollar.
Fortnite scams on the rise, children being ripped off via games
Kids playing the world's most popular video game are preyed on by criminals, UK cops warn.
Mark Fowler: Lack of new NZX listings must concern
COMMENT: If some businesses are to disappear from the NZX, where are the replacements?
NZ's dying life insurance industry
The life insurance industry is struggling to attract new buyers.
Company fined $40k for discharging 150 litres of oil into harbour
The oil is expected to persist in the harbour for one to two years.
Bitcoin market crash leaves graveyard of startups
The burst bubble has collected a few casualties.
Fletcher shares low enough for a takeover?
Fletcher Building shares have fallen so low it could be a bargain price for a buyer.
Share market research to go Pokemon-style
An equity research firm is to use augmented reality to appeal to more millennials.
Soper: What can we expect from Govt's fuel price inquiry?
COMMENT: In fact a raft of taxes are responsible for around half the price at the pump.
Oil shock: Qatar pulls out of OPEC
Qatar is the world's biggest exporter of liquid natural gas.
Brian Gaynor: NZX shelf life shockingly brief for too many
COMMENT: Directors with industry skills, strong emphasis on organic growth key.
The only currency performing worse than bitcoin is Venezuela's bolivar
This must surely make even the most fervent bitcoin supporter question the cryptocurrency.
NZ shares fall with blue chips A2, Ryman, F&P Healthcare gains
Shares fell in light trading as blue-chip stocks including A2 Milk followed Australia.
Bitcoin plunges to 13-month low as massive sell-off rips into market
Digital assets have now lost almost US$700 billion in value since January.
Bitcoin traders furious as major exchange fiddles with contracts
The issue reiterated the risk of using unregulated currency exchanges.
The US dollar faces an uncertain future
COMMENT: The greenback's place at the top isn't so certain any longer.
NZ stock exchange hit by computer problems
The outage could potentially affect trading when the market opens at 10am.
Bitcoin founder vs 'Bitcoin Jesus': legal battle turns personal
A fight is playing out between two of the most prominent names in bitcoin.
Troubled forex broker mulls bankruptcy
Director of Queen St firm under SFO investigation faces $4m claim from liquidators.
Wind-up of CBLI now looks inevitable
Opposition to application to liquidate is understood to have been withdrawn.
Taxpayer funding for Bitcoin startup draws brutal criticism
Vimba's founder, Sam Blackmore, sees the digital currency surging 60-fold to US$600,000.
Govt hands $330K grant to bitcoin startup
Callaghan Innovation backs startup that believes a bitcoin will surge to US$600,000.
NZX has hit refresh with a spring clean for its rule book
The NZX has "refreshed" its market structure and updated its listing rules.
Comment: Bitcoin has become a failed promise
It's been ten years of promises and little has materialised.
After the crash, is there any hope for bitcoin?
Investors want regulators to step in to give bitcoin legitimacy.
Medicinal cannabis firm heading for NZX
Cannasouth is planning to become NZ's first listed medicinal cannabis company.